Long Li is a seasoned professional in pharmacology and toxicology with extensive experience in translational science project management, particularly in supporting new drug research and development. Long served as a Sr. Principal Scientist and Associate Scientific Director at EMD Serono, Inc. from 2010 to 2018, and as a Toxicologist at Synta Pharma from 2000 to 2007. Currently, Long works as a Fellow in pharmacology and toxicology at Telix Pharmaceuticals Limited, contributing to the development of targeting radiopharmaceutical theranostic programs for oncology. Additionally, Long held the role of Director of Translational Study Management at ReCode Therapeutics in 2023, overseeing nonclinical study design and regulatory submissions. Long's academic background includes a medical degree from Tianjin Medical University, where they served as a Pathologist and Physician from 1989 to 1997.
This person is not in the org chart
This person is not in any teams
This person is not in any offices